Susquehanna International Group
PMVP icon

Susquehanna International Group’s PMV Pharmaceuticals PMVP Stock Holding History

Susquehanna International Group’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-78,784
Closed -$98.5K – 13896
2025
Q4 		$98.5K Buy
78,784
+53,150
+207% +$71.2K ﹤0.01% 11461
2025
Q3 		$35.9K Sell
25,634
-19,124
-43% -$26.5K ﹤0.01% 11945
2025
Q2 		$47.4K Buy
+44,758
New +$43.9K ﹤0.01% 12127
2024
Q4 		– Sell
-44,160
Closed -$65.8K – 12986
2024
Q3 		$65.8K Sell
44,160
-42,457
-49% -$65.6K ﹤0.01% 11269
2024
Q2 		$140K Sell
86,617
-65,774
-43% -$119K ﹤0.01% 10766
2024
Q1 		$259K Buy
152,391
+131,537
+631% +$246K ﹤0.01% 10042
2023
Q4 		$64.6K Sell
20,854
-129,253
-86% -$342K ﹤0.01% 11600
2023
Q3 		$922K Sell
150,107
-11,374
-7% -$78.2K ﹤0.01% 6804
2023
Q2 		$1.01M Sell
161,481
-179,502
-53% -$941K ﹤0.01% 6650
2023
Q1 		$1.63M Buy
340,983
+279,921
+458% +$1.97M ﹤0.01% 5603
2022
Q4 		$531K Sell
61,062
-42,412
-41% -$452K ﹤0.01% 7698
2022
Q3 		$1.23M Buy
103,474
+70,621
+215% +$1.02M ﹤0.01% 6106
2022
Q2 		$468K Sell
32,853
-9,546
-23% -$139K ﹤0.01% 8433
2022
Q1 		$883K Sell
42,399
-6,170
-13% -$109K ﹤0.01% 7444
2021
Q4 		$1.12M Buy
48,569
+7,512
+18% +$182K ﹤0.01% 6991
2021
Q3 		$1.22M Buy
41,057
+28,948
+239% +$924K ﹤0.01% 7028
2021
Q2 		$414K Buy
+12,109
New +$404K ﹤0.01% 10047

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Susquehanna International Group's PMVP Position: Q1 2026 in Review

Susquehanna International Group sold out of PMV Pharmaceuticals (PMVP) in Q1 2026, closing a stake of 78,784 shares — an estimated $98.5K sold.

Susquehanna International Group first reported a position in PMVP in Q2 2021 and held it in 17 quarters. The position peaked at $1.63M in Q1 2023. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • Susquehanna International Group reported no remaining PMV Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 78,784 PMV Pharmaceuticals shares in Q1 2026, an estimated $98.5K.
  • Susquehanna International Group first reported a position in PMV Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Susquehanna International Group's PMV Pharmaceuticals position peaked at $1.63M in Q1 2023.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.